Food News and Research

RSS

Results of Creutzfeldt-Jakob disease research in people who received human growth hormone from cadavers

The largest study of its kind, designed to track the development of Creutzfeldt-Jakob disease in people who received human growth hormone from cadavers, has found that the vast majority of those who received the hormone did not contract the fatal condition. However, some recipients (26 out of approximately 7,700) did develop the disease.

7 Apr 2004

International obesity experts form a team to review and evaluate obesity

In an effort to help medical professionals, policy-makers, researchers, the news media and the general public evaluate the quality and usefulness of obesity research, a group of international obesity experts has formed a team that will review and evaluate published research papers in the field of obesity.

7 Apr 2004

Effects of lead in petrol are well-known however a recent additive to petrol manganese may be just as toxic

The disastrous environmental and health effects of lead in petrol are well-known, and western countries have been phasing it out for many years now. However, a recent additive to petrol - manganese - may be just as toxic. A Macquarie University study aims to find out.

7 Apr 2004

Analysis of Bacterial Genomes Begins to Unravel Complex Story of Metabolic Evolution

In a paper published in the current issue of the journal Molecular Biology and Evolution , Arizona State University biochemists Jason Raymond, Christopher Staples and Robert Blankenship and Rice University's Janet Siefert do an analysis of the genomes of a large group of bacteria and archaea, comparing in particular similar genes that produce the protein nitrogenase.

7 Apr 2004

FDA accepts REMICADE® (infliximab) for the treatment of early rheumatoid arthritis

Centocor, Inc., announced today that the U.S. Food and Drug Administration (FDA) has accepted its filing of a supplemental Biologics License Application (sBLA) for REMICADE® (infliximab) as first-line therapy, in combination with methotrexate, for the treatment of early rheumatoid arthritis (RA) patients with moderately-to-severely active disease. REMICADE®, in combination with methotrexate, is currently indicated in the U.S. for reducing signs and symptoms, inhibiting the progression of structural damage and improving physical function in patients with moderately-to-severely active RA who have had an inadequate response to methotrexate alone.

6 Apr 2004

The Food and Drug Administration issues warning on antidepressants

The Food and Drug Administration (FDA) is issuing a warning about the possibility of worsening depression or suicidal thought in people, particularly children, who take any of 10 popular antidepressants, especially at the beginning of treatment or when the dosage is changed.

6 Apr 2004

New York - Due to changing blood donor criteria, donor deferral rates have been increasing since 1999

Due to changing blood donor criteria, donor deferral rates have been increasing since 1999 with trend lines predicting additional deferral increases. This predicament has created a critical demand for new people to step forward to donate to ensure there is an adequate supply of blood for hospital patients in New York and New Jersey who require life-saving transfusions, reports New York Blood Center (NYBC) officials.

6 Apr 2004

Consumer trust in food is high in the United Kingdom, Denmark, and Norway, but low in Italy and Portugal

Consumer trust in food is high in the United Kingdom, Denmark, and Norway, but low in Italy and Portugal and relatively low in Germany. Research also shows that consumers in these countries are most sceptical about meat products, fast-food outlets and food processors.

5 Apr 2004

Functional food, beyond providing a purely nutritional value, may promote health or reduce the risk of disease

Functional food, beyond providing a purely nutritional value, may promote health or reduce the risk of disease. An example is food meant to lower the cholesterol level. During the past few years, the potential benefits posed by functional foods have led to an increased interest by producers and consumers as well as a broader range of such products on the market worldwide.

5 Apr 2004

Cordis Cardiology receives warning from the U.S. Food and Drug Administration

Cordis Cardiology, a division of Cordis Corporation, a Johnson & Johnson Company, reported today that it received a warning letter from the U.S. Food and Drug Administration (FDA) regarding FDA's observations concerning the Good Manufacturing Practice (GMP) regulations.

5 Apr 2004

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

ProMetic Life Sciences Inc. has announced today that its joint venture with the American Red Cross, Pathogen Removal and Diagnostic Technology Inc. ("PRDT"), has confirmed that treatment of TSE spiked red blood cell concentrate with its Prion Reduction Device results in a significant decrease in associated infectivity.

5 Apr 2004

Upcoming symposium to examine mercury exposure

The AMA is co-sponsoring a symposium for CME credit this month in Tampa, Fla., on the medical and public health aspects of mercury exposure. "Mercury: Medical and Public Health Issues" will be held from April 28-30 at the Tampa Marriott Waterside Hotel and Marina.

5 Apr 2004

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

Merck/Schering-Plough Pharmaceuticals today announced the regulatory approval of INEGYTM (ezetimibe/simvastatin) in Germany for the treatment of elevated cholesterol (hypercholesterolemia). INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or ‘bad’ cholesterol), along with diet and exercise, through dual inhibition by inhibiting cholesterol production in the liver and absorption in the intestine. The approval of INEGY in Germany represents the first approval in Europe for ezetimibe/simvastatin tablets and the first step in seeking marketing approval throughout the European Union (EU) under the EU’s mutual recognition procedure.

4 Apr 2004

Dangers of ‘hidden ingredients’ in breakfast cereals

The Stroke Association warned today against the hidden dangers from the high levels of salt, sugar and fat found in many popular breakfast cereals enjoyed by both children and adults.

4 Apr 2004

New treatment for Tourette Syndrome, patients experience significant resolution of symptoms following brain surgery

A neurosurgical team at University Hospitals of Cleveland (UHC) has, for the first time in North America, applied a new surgical approach to the treatment of Tourette syndrome, resulting in the immediate and nearly complete resolution of symptoms for the patient, who has suffered from this neurologic disorder since he was a child.

1 Apr 2004

SARS virus vaccine stimulates protective immune response

An experimental vaccine prevents the SARS virus from replicating in laboratory mice, according to a new report in the April 1 issue of Nature. Scientists at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, developed the vaccine. The vaccine was tested in a mouse model of SARS infection recently validated by other NIAID investigators.

31 Mar 2004

FDA has approved Zyprexa, injectable anti-psychotic drug

Physicians have a new fast-acting option for controlling the potentially crippling effects of acute agitation in patients suffering with schizophrenia and bipolar mania. The U.S. Food and Drug Administration (FDA) has approved Zyprexa® IntraMuscular (olanzapine for injection), an injectable form of Lilly's top-selling medication.

30 Mar 2004

Embryonic stem cells attached to a gel matrix instead of suspended in solution

30 Mar 2004

New storage method amplifies cells available for science

Like many other kinds of cells used in biomedical research, human embryonic stem cells are stored and transported in a cryopreserved state, frozen to -320 degrees Fahrenheit, the temperature of their liquid nitrogen storage bath. But when scientists thaw the cells for use in the lab, less than 1 percent awake from their frigid slumber and assume their undifferentiated state. This 'blank slate' form is characteristic of stem cells and essential for the basic science required before the promising cells are ready for the clinic.

30 Mar 2004

Newly formed FAS Center for Systems Neuroscience

Harvard has long been recognized for its strength in neuroscience: Researchers in the Faculty of Arts and Sciences (FAS) are leaders in studies of behavior, perception, and brain development, while Harvard Medical School (HMS) was the first in the nation to establish a department of neurobiology.

29 Mar 2004

Food News and Research

Results of Creutzfeldt-Jakob disease research in people who received human growth hormone from cadavers

International obesity experts form a team to review and evaluate obesity

Effects of lead in petrol are well-known however a recent additive to petrol manganese may be just as toxic

Analysis of Bacterial Genomes Begins to Unravel Complex Story of Metabolic Evolution

FDA accepts REMICADE® (infliximab) for the treatment of early rheumatoid arthritis

The Food and Drug Administration issues warning on antidepressants

New York - Due to changing blood donor criteria, donor deferral rates have been increasing since 1999

Consumer trust in food is high in the United Kingdom, Denmark, and Norway, but low in Italy and Portugal

Functional food, beyond providing a purely nutritional value, may promote health or reduce the risk of disease

Cordis Cardiology receives warning from the U.S. Food and Drug Administration

New device filters blood supplies on-site reducing the possible transmission of Creutzfeldt-Jakob disease

Upcoming symposium to examine mercury exposure

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

Dangers of ‘hidden ingredients’ in breakfast cereals

New treatment for Tourette Syndrome, patients experience significant resolution of symptoms following brain surgery

SARS virus vaccine stimulates protective immune response

FDA has approved Zyprexa, injectable anti-psychotic drug

Embryonic stem cells attached to a gel matrix instead of suspended in solution

New storage method amplifies cells available for science

Newly formed FAS Center for Systems Neuroscience

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News